Richard 2000.
| Methods | Randomised, double‐blind Multicentre study | |
| Participants | Number: 594 women Age: 18‐55 years Inclusion criteria: symptomatic UAC | |
| Interventions | GROUP 1
3 days oral rufloxacin (250 mg once daily) GROUP 2 3 days oral pefloxacin (200 mg twice daily) |
|
| Outcomes | Bacteriological and clinical response Adverse events | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Allocation concealment? | Low risk | A ‐ Adequate |